A Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes Mellitus
Clinical trial NCT01514838 · TERMINATED
Trial details
- NCT number
- NCT01514838
- Sponsor
- Astellas Pharma Inc
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-23
- Primary completion
- 2012-10-19
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.